SENNA

Pharmacy Tech Startup LUDA Partners Opens Exclusive Funding Round for Industry Insiders

MADRID - LUDA Partners, a Spanish company specializing in the digitization and connectivity of pharmacies, has announced the launch of a new investment round exclusively targeting pharmaceutical industry professionals.

The minimum participation is just €2,500, an accessible format aimed at strengthening the strategic ties between LUDA and the sector fueling its growth. This allows pharmacists, a key pillar of the business, to take on a greater ownership stake.

LUDA has confirmed that participating professionals will receive the same economic terms as the major funds currently in its shareholder base, including lead investor Moira Capital Partners. Over the past few years, many pharmacists and industry players have expressed interest in investing in LUDA.

In the startup's last funding round, the overwhelming response from the sector required an expansion, ultimately raising close to €500,000 with over 50% of shareholders now comprising pharmacies and industry agents. Those who have already participated are acutely aware of the value - their €1 invested in the past is now worth €27.

"With this round, LUDA and Moira are reinforcing our commitment to an open innovation model where the industry itself can be an active part of an idea already crossing borders," said Luis Martín Lázaro, LUDA's co-founder. "We are adapting to the reality of a sector where cooperatives and manufacturers enable this direct, strategic participation."

The fresh capital injection will be used to consolidate LUDA's position in the Spanish market and accelerate its international expansion, particularly in Ireland and the UK. Industry sources familiar with the matter say the move reflects LUDA's strategy of deepening ties with pharmacists as key stakeholders, rather than simply treating them as customers.

Moira Capital, which led LUDA's last funding round, has praised the startup's ability to drive digitalization in a traditionally conservative sector. "Empowering pharmacists as owners and active participants is a unique approach that aligns incentives and will be crucial to LUDA's continued growth," a Moira spokesperson told reporters.

The exclusive funding round comes as LUDA looks to cement its position as a leader in pharmacy tech solutions across Europe. Industry analysts note the strategic value in giving the end-users a vested interest in the company's success, rather than relying solely on outside investors.